麻豆淫院

Leishmaniasis is a parasitic disease that affects up to 1 million people worldwide each year. It is caused by the protozoan Leishmania, transmitted through the bite of a sandfly. Once inside its host鈥攈uman or animal鈥攖he parasite settles in immune cells called macrophages and multiplies within small bubble-like structures known as parasitophorous vacuoles.

To replicate, Leishmania needs lipids鈥攅ssential molecules for many cellular functions. Contrary to previous beliefs, the amastigote form of the parasite, which multiplies in humans, does not produce its own lipids. Instead, it must extract them directly from the host cell.

This discovery, made by the team of Professor Albert Descoteaux at Institut national de la recherche scientifique (INRS), was recently in PLOS Pathogens.

A host protein hijacked for parasitic purposes

As part of her Ph.D. research at INRS, Ilona Gdovinova uncovered a key mechanism by which Leishmania acquires a class of lipids known as sphingolipids. She demonstrated that the parasite hijacks a host macrophage protein called VAPA, which normally facilitates lipid transport between cellular compartments.

By observing infected macrophages, the team found that VAPA accumulates around the vacuoles containing the parasite. When this protein is blocked, the vacuole can no longer expand, and the parasite stops multiplying.

"The parasite uses VAPA as a bridge to channel the lipids it needs. It even disrupts the protein's normal interactions to better exploit it," explains Ilona Gdovinova, doctoral student in virology and immunology at INRS and first author of the study.

"This discovery highlights how finely parasites can manipulate cellular functions to ensure their survival," she adds.

The team, based at the INRS Armand-Frappier Sant茅 Biotechnologie Research Centre, also found that VAPA helps the parasite transport a key virulence molecule to another part of the host cell. This shows that the protein plays a crucial role in two-way exchanges between the parasite and its host.

"By identifying a critical mechanism for Leishmania's acquisition of sphingolipids, this work opens the door to new strategies to block its replication," says Professor Albert Descoteaux, director of the Infectiopole and lead author of the study.

A specialist in host-pathogen interactions and a member of the Pasteur Network, Professor Descoteaux emphasizes the importance of understanding how these pathogens replicate in humans. This knowledge is essential for developing new therapeutic or preventive approaches鈥攅specially as drug resistance spreads and treatment options remain limited.